[Perspective of prevention and treatment for allergic diseases].
Ishii
Yasuyuki
Y
Laboratory for Vaccine Design, RIKEN Research Institute for Allergy and Immunology, 1-7-22, Suehiro-chou, Tsurumi, Yokohama, Kanagawa 230-0045, Japan.
D000485:Allergens; D000818:Animals; D017951:Antigen Presentation; D001402:B-Lymphocytes / Q000166:cytology; D002454:Cell Differentiation; D015195:Drug Design; D005699:Galactosylceramides; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control* / Q000628:therapy*; D007073:Immunoglobulin E; D008081:Liposomes; D013601:T-Lymphocytes / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology; D050378:T-Lymphocytes, Regulatory; D014612:Vaccines
D000485:Allergens; D005699:Galactosylceramides; D008081:Liposomes; D014612:Vaccines; C493154:alpha-galactosylceramide; D007073:Immunoglobulin E